Research progress of presepsin in the early diagnosis of neonatal sepsis
10.3760/cma.j.cn101721-20221026-000497
- VernacularTitle:Presepsin在新生儿败血症早期诊断中的研究进展
- Author:
Huaqing ZHANG
1
;
Xiaoyan HU
Author Information
1. 北京大学深圳医院儿科，深圳 518036
- Keywords:
Neonatal sepsis;
Presepsin;
Procalcitonin;
C-reaction protein
- From:
Clinical Medicine of China
2024;40(3):237-240
- CountryChina
- Language:Chinese
-
Abstract:
Neonatal sepsis is a serious infectious disease in the neonatal period, which can cause severe complications such as septic shock and multiple organ failure, and endangering children's lives. Early diagnosis is the key to improve the prognosis. Because the clinical manifestations of neonatal sepsis are often atypical and difficult to be detected early, reliable infection markers are urgently needed to help the early diagnosis. Recently, a novel marker Presepsin (soluble CD14 subtype, sCD14-TS) has been found, which is expected to be an ideal marker for the early diagnosis of neonatal sepsis.
